Dapagliflozin for the treatment of type 2 diabetes mellitus – an update-Reference-Cited by-同舟云学术

Dapagliflozin for the treatment of type 2 diabetes mellitus – an update

Published:2021-07-28 Issue:17 Volume:22 Page:2303-2310
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Nicholson Martha K¹²,Ghazal Asswad Randa¹²^ORCID,Wilding John PH¹²

Affiliation:

1. Department of Diabetes and Endocrinology, Liverpool University Hospitals NHS Foundation Trust, Clinical Sciences Centre, Aintree University Hospital, Liverpool, UK

2. Department of Metabolic and Cardiovascular Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2021.1953471

Reference51 articles.

1. International Diabetes Federation. IDF diabetes atlas 2019. [cited 2021 Apr 5]. Available from: https://www.diabetesatlas.org/en/sections/worldwide-toll-of-diabetes.html

2. We Can Change the Natural History of Type 2 Diabetes

3. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

4. Endocrine Pharmacology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of PES1 in disease: A promising therapeutic target?;Gene;2025-01

2. Dapagliflozin: A new hope for the therapeutic treatment of type 2 diabetes mellitus;European Journal of Medicinal Chemistry Reports;2024-08

3. The MeViDa Study: Bioequivalence Study of FDC of Dapagliflozin, Vildagliptin SR and Metformin SR in Healthy Indian Volunteers: A Randomized, Open-Label, Crossover Study;Journal of Drug Delivery and Therapeutics;2024-07-15

4. Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin;European Journal of Clinical Pharmacology;2024-06-10

5. Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use;Pharmaceuticals;2024-03-26